DE:G1G Stock Latest News
Company AnnouncementsZelira Clinches US$33m HOPE® 1 Funding Deal to Advance FDA Pathway2d ago
Company AnnouncementsASX Flags Possible Delisting of Zelira Therapeutics Over Unpaid Listing Fees2M ago
Company AnnouncementsZelira Secures US$33m for HOPE® 1 SPV to Advance FDA Autism Trial3M ago
Company AnnouncementsASX Sets Deadlines for Long-Term Suspended Companies Facing Delisting Risk3M ago
Company AnnouncementsZelira Director Converts Convertible Notes, Boosting Equity Stake4M ago
Company AnnouncementsZelira Therapeutics Ceases 2.25 Million Convertible Notes4M ago
- Company AnnouncementsZelira Secures Director Loan on Premium-Priced Convertible Terms7M ago
Company AnnouncementsZelira Raises US$33m for HOPE® 1 SPV to Accelerate FDA Pathway9M ago
Company AnnouncementsZelira Secures US$33m Strategic Investment to Advance HOPE® 1 Autism Therapy9M ago- Company AnnouncementsZelira Therapeutics Adjusts Director’s Interest with Convertible Notes11M ago
Company AnnouncementsZelira Therapeutics Issues Unquoted Convertible Notes11M ago
Company AnnouncementsZelira Therapeutics Focuses on Operational Scale in 202511M ago
Company AnnouncementsZelira Therapeutics Secures R&D Loan and Advances Clinical Trials1y ago- Company AnnouncementsZelira Therapeutics Announces Cessation of Securities1y ago
Company AnnouncementsZelira Therapeutics Announces Key Resolutions for Upcoming AGM1y ago
Company AnnouncementsZelira Therapeutics Releases 2025 Corporate Governance Statement1y agoCompany AnnouncementsZelira Therapeutics Reports Increased Loss Amidst Clinical Progress and Expansion Plans1y ago